Company Filing History:
Years Active: 2001
Title: Sven Bergström: Innovator in Borrelia Research
Introduction
Sven Bergström is a notable inventor based in Umeå, Sweden. He has made significant contributions to the field of microbiology, particularly in the study of Borrelia, the bacteria responsible for Lyme disease. His work has implications for both vaccine development and diagnostic methods.
Latest Patents
Bergström holds a patent for a 66 kDa antigen from Borrelia. This patent discloses nucleic acid fragments that encode a polypeptide antigen reactive with antisera from rabbits immunized with a 66 kDa protein from IP90. The presence of these nucleic acid fragments, as well as the polypeptide antigen, has been demonstrated in three strains of Borrelia sensu lato. However, they are substantially absent from at least 95% of randomly selected strains. The encoded polypeptide is surface-exposed on the bacterial surface, is highly conserved, and is potentially useful as a vaccine agent and as a diagnostic agent for infections. The patent also includes methods for producing the polypeptide antigen and antibodies directed against it.
Career Highlights
Bergström's career is marked by his dedication to understanding Borrelia and its implications for human health. His research has led to advancements in the field and has positioned him as a key figure in microbiological research.
Collaborations
Bergström has collaborated with notable researchers, including Alan G. Barbour, enhancing the depth and impact of his work in the scientific community.
Conclusion
Sven Bergström's contributions to the field of microbiology, particularly through his patent on the 66 kDa antigen from Borrelia, highlight his role as an innovator in the fight against infectious diseases. His work continues to influence vaccine development and diagnostic methods, showcasing the importance of research in public health.